|
CRF and Fogarty Innovation Announce Strategic Merger
|
|
Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified Coronary Lesions Noninferior to Intravascular Lithotripsy
|
|
Novel Sirolimus-Eluting Balloon Appears Noninferior to Conventional Therapies for Treatment of In-stent Restenosis
|
|
Cutting Balloon Treatment Prior to Stent Placement Comparable to Intravascular Lithotripsy for Patients with Calcified Coronary Artery Disease
|
|
PCI with a Sirolimus-Eluting Balloon and Provisional Stenting Shows Comparable Outcomes to Routine DES Implantation For Treatment of De Novo Coronary Lesions
|
|
CRF Unveils 2025 SET-10 Rankings Spotlighting Global Leaders in Cardiovascular Research
|
|
CRF and the Jon DeHaan Foundation to Launch TCT AI Lab at TCT 2025
|
|
Carlos Collet, MD, PhD, Joins CRF as Director, Cardiovascular Imaging, Physiology and Translational Therapeutics
|
|
CRF Announces TCT 2025 Late-Breaking Clinical Trials and Science
|
|
New York Valves™ 2025 Late-Breaking Clinical Trials Announced
|
